Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo Chinese For Medical Students & Physicians A complete 20-lesson, 300-page Chinese course with a companion app in 21 languages — free forever. Download the free PDF: Amedeo Chinese PDF

Autoimmune Disorders

Free Subscription Articles published in J Rheumatol Retrieve available abstracts of 162 articles: HTML format

Single Articles

July 2026
1. YILDIZ M, Konte EK, Aslan E, Akay N, et al
   Classification of Nonsystemic Juvenile Idiopathic Arthritis Using the Provisional Paediatric Rheumatology International Trials Organisation Criteria.
   J Rheumatol. 2026;53:800-807.
   PubMed     Abstract available
   
   
   
2. KOBRIN DM, Brown DG, Burbelo PD, Workman L, et al
   Examination of HLA-DRB1*15-linked Candidate Antigens in Still Disease With and Without Lung Disease and Drug-Associated Immune Reactions.
   J Rheumatol. 2026;53:816-822.
   PubMed     Abstract available
   
   
   
3. MORAND EF, Jones SA
   PROducing More Evidence to Reduce Glucocorticoids in Systemic Lupus Erythematosus: Putting Patient-Reported Outcomes in the Picture.
   J Rheumatol. 2026 Jul 1:jrheum.2026-0502. doi: 10.3899/jrheum.2026-0502.
   PubMed    
   
   
   
4. DEL PAPA N, Greco R
   Predicting Relapse After Autologous Hematopoietic Cell Transplantation in Systemic Sclerosis: What Autoantibodies Can and Cannot Tell Us.
   J Rheumatol. 2026 Jul 1:jrheum.2026-0544. doi: 10.3899/jrheum.2026-0544.
   PubMed    
   
   
   June 2026
5. LECLAIR V, Berger C, Bouchard-Marmen M, Bourre-Tessier J, et al
   Does the ACR/EULAR Total Improvement Score reflect how individuals with autoimmune inflammatory myopathies feel and function?
   J Rheumatol. 2026 Jun 15:jrheum.2026-0046. doi: 10.3899/jrheum.2026-0046.
   PubMed     Abstract available
   
   
   
6. GARCIA-ESCUDERO P, Iturricha Ochoa de Echaguen A, Beltran de Otalora Garcia S, Lopez I Gomez M, et al
   Uncharted Territory: Adult-Onset Autoinflammatory Syndrome With a Newly Identified Mutation in the Coatomer WD-Associated Region of COPA Gene.
   J Rheumatol. 2026 Jun 15:jrheum.2025-1267. doi: 10.3899/jrheum.2025-1267.
   PubMed    
   
   
   
7. JAMES EA
   From Mouth to Joint: Citrullinated Bacteria in Driving Synovial Autoimmunity.
   J Rheumatol. 2026 Jun 1:jrheum.2026-0410. doi: 10.3899/jrheum.2026-0410.
   PubMed    
   
   
   
8. ELOSEILY E, Romankevych I, Sabit T, Berklite L, et al
   Hepatic Manifestations in Systemic Juvenile Idiopathic Arthritis and Macrophage Activation Syndrome.
   J Rheumatol. 2026;53:669-678.
   PubMed     Abstract available
   
   
   May 2026
9. CLIFFORD AH, Thai J, Yip A, Homik J, et al
   How Often Does Follow up 18F-FDG PET Improve in Treated Patients with Giant Cell Arteritis: a Systematic Review and Meta-Analysis.
   J Rheumatol. 2026 May 15:jrheum.2026-0050. doi: 10.3899/jrheum.2026-0050.
   PubMed     Abstract available
   
   
   
10. RANDELL RL, Ardalan K, Carson NB, Li Z, et al
    Sex Differences in PROMIS Pediatric Depressive Symptoms, Anxiety, and Psychological Stress Among Children and Adolescents Living With Pediatric Rheumatic Diseases.
    J Rheumatol. 2026;53:547-555.
    PubMed     Abstract available
    
    
    
11. MISZTAL MC, Mukherjee T, Couse M, Dissanayake D, et al
    Novel DNASE2 Variants Linked With Neonatal Acute Liver Failure and Monogenic Systemic Lupus Erythematosus.
    J Rheumatol. 2026 May 1:jrheum.2025-1111. doi: 10.3899/jrheum.2025-1111.
    PubMed    
    
    
    April 2026
12. REBOLLO-GIMENEZ AI, Baird T, Feldman BM, Hinze C, et al
    Systematic literature review informing PReS/CARRA-endorsed recommendations for the treat-to-target strategy in juvenile dermatomyositis.
    J Rheumatol. 2026 Apr 15:jrheum.2025-1157. doi: 10.3899/jrheum.2025-1157.
    PubMed     Abstract available
    
    
    
13. LEVIN D, Choi M, Kawasoe J, Durand C, et al
    Autoantibodies and Relapse of Systemic Sclerosis After Autologous Hematopoietic Cell Transplantation.
    J Rheumatol. 2026 Apr 15:jrheum.2025-0987. doi: 10.3899/jrheum.2025-0987.
    PubMed     Abstract available
    
    
    
14. HARRIS JG, Singleton JH, Ting TV, Oberle EJ, et al
    Evaluation of Health Disparities in Outcomes of Patients With Juvenile Idiopathic Arthritis.
    J Rheumatol. 2026;53:435-442.
    PubMed     Abstract available
    
    
    
15. SONG J, Jiang H, Wang X, Gong K, et al
    Evolution of the Diagnostic Paradigm for Giant Cell Arteritis: From Histopathology to Multi-Modal Imaging Integration Running title: GCA: Histology to Imaging.
    J Rheumatol. 2026 Apr 1:jrheum.2025-1205. doi: 10.3899/jrheum.2025-1205.
    PubMed     Abstract available
    
    
    
16. MCMAHON M, Skaggs BJ
    Rethinking Cardiovascular Screening in Systemic Lupus Erythematosus.
    J Rheumatol. 2026 Apr 1:jrheum.2026-0136. doi: 10.3899/jrheum.2026-0136.
    PubMed    
    
    
    
17. MILLER-BARMAK A, Mandel-Shorer N, Tobias L, Butbul Aviel Y, et al
    Antiphospholipid Syndrome in Identical Pediatric Twins.
    J Rheumatol. 2026 Apr 1:jrheum.2025-0472. doi: 10.3899/jrheum.2025-0472.
    PubMed    
    
    
    March 2026
18. CONCANNON HR, Sun K, Rogers JL, Clowse MEB, et al
    Differences in Self-Reported Medication Nonadherence and its Drivers in Young Adults versus Older Adults with Systemic Lupus Erythematosus.
    J Rheumatol. 2026 Mar 1:jrheum.2025-0602. doi: 10.3899/jrheum.2025-0602.
    PubMed     Abstract available
    
    
    February 2026
19. MANZI S
    Trends in Acute Coronary Syndromes in Systemic Lupus Erythematosus: Are We Moving in the Right Direction?
    J Rheumatol. 2026 Feb 15:jrheum.2026-0067. doi: 10.3899/jrheum.2026-0067.
    PubMed    
    
    
    
20. RONDLA M, Zaazouee MS, Perumangote Vasudevan AA, Mathialagan K, et al
    Gut Microbiota as a Biomarker and Target in Biologic Therapy for Autoimmune and Immune-Mediated Arthritis- a Systematic Review.
    J Rheumatol. 2026 Feb 15:jrheum.2025-0915. doi: 10.3899/jrheum.2025-0915.
    PubMed     Abstract available
    
    
    
21. SINGH A, Gamboa-Cardenas RV, Pimentel-Quiroz VR, Rodriguez-Bellido Z, et al
    Association of Daily Glucocorticoid Dose With Worse Patient-Reported Outcomes in Systemic Lupus Erythematosus: Data From the Almenara Lupus Cohort.
    J Rheumatol. 2026 Feb 15:jrheum.2025-0394. doi: 10.3899/jrheum.2025-0394.
    PubMed     Abstract available
    
    
    
22. TSAI Z, Huber AM, Oen K, Proulx-Gauthier JP, et al
    Effect of Treatment Changes on Health-Related Quality of Life in Canadian Children With Juvenile Idiopathic Arthritis: Results From ReACCh-Out and CAPRI.
    J Rheumatol. 2026;53:186-193.
    PubMed     Abstract available
    
    
    
23. KIM K, Claybaugh D, Patino-Martinez E, Temesgen-Oyelakin Y, et al
    Genome-Wide Association Study Identifies Genetic Loci for Antibody Response to SARS-CoV-2 Vaccines in Patients With Systemic Autoimmune Diseases and Healthy Individuals.
    J Rheumatol. 2026 Feb 1:jrheum.2025-0770. doi: 10.3899/jrheum.2025-0770.
    PubMed     Abstract available
    
    
    
24. FORNARO M, Lacedonia D, Cavagna L, Airo P, et al
    Prognostic and Functional Trajectories in Idiopathic Pulmonary Fibrosis and Systemic Autoimmune Rheumatic Disease-Associated Interstitial Lung Disease: Insights From an Italian Multicenter Cohort.
    J Rheumatol. 2026 Feb 1:jrheum.2025-0610. doi: 10.3899/jrheum.2025-0610.
    PubMed     Abstract available
    
    
    January 2026
25. PLANTINGA LC, Fitzpatrick J, Dey M, Dall'Era M, et al
    Perceived and Objective Physical Function in Two U.S., Population-Based Cohorts of Adults with Systemic Lupus Erythematosus.
    J Rheumatol. 2026 Jan 15:jrheum.2025-0857. doi: 10.3899/jrheum.2025-0857.
    PubMed     Abstract available
    
    
    
26. TAUBMANN J, Hagen M, Muller F, Wirsching A, et al
    Effects of CD19 CAR T Cell Therapy on Quality of Life and Direct Healthcare Costs in Systemic Lupus Erythematosus: A Preliminary Analysis.
    J Rheumatol. 2026;53:33-37.
    PubMed     Abstract available
    
    
    
27. WEISS PF, Ruperto N, Quebe-Fehling E, Shew A, et al
    Juvenile Spondyloarthritis Disease Activity Index Validation in Enthesitis-Related Arthritis and Juvenile Psoriatic Arthritis in a Prospective Clinical Trial Setting.
    J Rheumatol. 2026;53:85-94.
    PubMed     Abstract available
    
    
    December 2025
28. QIAO J, Ma Y, Zhang X, Zhu G, et al
    Evaluating the Applicability of the EULAR/ACR-2019, SLICC-2012, and ACR-1997 Classification Criteria for Systemic Lupus Erythematosus in Children: a multicenter study.
    J Rheumatol. 2025 Dec 15:jrheum.2025-0559. doi: 10.3899/jrheum.2025-0559.
    PubMed     Abstract available
    
    
    
29. BENSON KRK, Becerril A, Park J, Plantinga L, et al
    The Impact of Everyday Discrimination on Systemic Lupus Erythematous Disease Activity and Mental Health Outcomes.
    J Rheumatol. 2025 Dec 15:jrheum.2025-0631. doi: 10.3899/jrheum.2025-0631.
    PubMed     Abstract available
    
    
    
30. ALY S, Parastandehchehr G, Bernatsky S, Vinet E, et al
    A Global Survey of Quinacrine Use in Systemic and Cutaneous Lupus Erythematosus.
    J Rheumatol. 2025 Dec 1:jrheum.2025-0757. doi: 10.3899/jrheum.2025-0757.
    PubMed     Abstract available
    
    
    
31. DAVIS NA, Wang J, Wang X, Getachew LS, et al
    Investigating factors associated with respiratory syncytial virus vaccination and breakthrough infection among patients with systemic autoimmune rheumatic diseases.
    J Rheumatol. 2025 Dec 1:jrheum.2025-0934. doi: 10.3899/jrheum.2025-0934.
    PubMed     Abstract available
    
    
    November 2025
32. O'CONNOR SK, Devarajan P, Liu J, Maldonado MA, et al
    The Renal Activity Index for Lupus: Validation for Prediction of Kidney Inflammation in Adult Patients with Lupus Nephritis.
    J Rheumatol. 2025 Nov 15:jrheum.2025-0504. doi: 10.3899/jrheum.2025-0504.
    PubMed     Abstract available
    
    
    
33. PATEL H, Stoots S, Von Feldt J, Baker JF, et al
    Performance of Risk Score Calculators in the Identification of Coronary Artery Calcification in Patients with Systemic Lupus Erythematosus.
    J Rheumatol. 2025 Nov 15:jrheum.2025-0465. doi: 10.3899/jrheum.2025-0465.
    PubMed     Abstract available
    
    
    
34. PARPERIS K, Bertsias G, Lampi M, Constantinou M, et al
    Time trends in acute coronary syndrome hospitalizations and outcomes in patients with Systemic Lupus Erythematosus: A US inpatient cohort analysis.
    J Rheumatol. 2025 Nov 15:jrheum.2025-0627. doi: 10.3899/jrheum.2025-0627.
    PubMed     Abstract available
    
    
    
35. QI W, Yuen SY, Popescu ML, Yang R, et al
    The Burden of Enthesitis, Inflammatory Arthritis and Tenosynovitis on Musculoskeletal Ultrasound in Systemic Lupus Erythematous: A Scoping Review.
    J Rheumatol. 2025 Nov 15:jrheum.2025-0684. doi: 10.3899/jrheum.2025-0684.
    PubMed     Abstract available
    
    
    
36. MAYO-JUANATEY A, Castaneda S, Calvo-Rio V, Garijo-Bufort M, et al
    Anifrolumab in Systemic Lupus Erythematosus With Severe Hematological Manifestations: A Spanish Multicenter Study.
    J Rheumatol. 2025 Nov 5:jrheum.2025-0658.C1. doi: 10.3899/jrheum.2025-0658.
    PubMed     Abstract available
    
    
    
37. CHAN YN, Ardalan K, Lin L, Chen D, et al
    Congruence Between Child Self-Reported and Caregiver-Proxy Health-Related Quality of Life in Children with Juvenile Idiopathic Arthritis and Systemic Lupus Erythematosus.
    J Rheumatol. 2025 Nov 1:jrheum.2025-0598. doi: 10.3899/jrheum.2025-0598.
    PubMed     Abstract available
    
    
    
38. CARLI L, Cavagna L, Cardelli C, Fattorini F, et al
    Anifrolumab therapy in Dermatomyositis: new insights from refractory patients.
    J Rheumatol. 2025 Nov 1:jrheum.2025-0773. doi: 10.3899/jrheum.2025-0773.
    PubMed     Abstract available
    
    
    
39. BARONAITE HANSEN R, Faurschou M, Jacobsen S
    Comorbidity Development and Mortality During 10 Years of Follow-up in Danish Nationwide Cohort of 3,178 Patients with Systemic Lupus Erythematosus.
    J Rheumatol. 2025 Nov 1:jrheum.2025-0015. doi: 10.3899/jrheum.2025-0015.
    PubMed     Abstract available
    
    
    
40. KILBAS G, Ayduran S, Sener S, Coskuner T, et al
    Results of a Nationwide Multicenter Study in Childhood Sjogren Disease.
    J Rheumatol. 2025;52:1141-1150.
    PubMed     Abstract available
    
    
    
41. FLATMAN LK, Bernatsky S, Berard A, Vinet E, et al
    Patterns of Use and Discontinuation for Tumor Necrosis Factor Inhibitors in Pregnant Women: Insights From a Real-World Sample.
    J Rheumatol. 2025;52:1159-1165.
    PubMed     Abstract available
    
    
    October 2025
42. OGBONNAYA SA, Williams S, Lightbourne M, Brown RJ, et al
    Type B Insulin Resistance: A Case Report of a Rare Complication of Systemic Lupus Erythematosus.
    J Rheumatol. 2025 Oct 15:jrheum.2025-0533. doi: 10.3899/jrheum.2025-0533.
    PubMed    
    
    
    
43. SRINIVASALU H, Beukelman T, Dennos A, Chen A, et al
    Juvenile Psoriatic Arthritis Inception Cohort in the Childhood Arthritis and Rheumatology Research Alliance (CARRA) Registry: Characteristics and Early Disease Outcomes.
    J Rheumatol. 2025;52:1013-1020.
    PubMed     Abstract available
    
    
    
44. PONGTARAKULPANIT N, Bishnoi A, Chandra T, Dzanko S, et al
    Quantifying Cutaneous Dermatomyositis: A Novel 3D Image-based Approach.
    J Rheumatol. 2025 Oct 1:jrheum.2025-0537. doi: 10.3899/jrheum.2025-0537.
    PubMed     Abstract available
    
    
    
45. LOPEZ-MARTINEZ J, Esplugues Clos J, Fernandez-Valmana A, Feijoo-Masso C, et al
    Renal AA Amyloidosis Associated With Systemic Lupus Erythematosus Treated With Anakinra.
    J Rheumatol. 2025 Oct 1:jrheum.2025-0431. doi: 10.3899/jrheum.2025-0431.
    PubMed    
    
    
    
46. MAYO-JUANATEY A, Castaneda S, Calvo-Rio V, Garijo-Bufort M, et al
    Anifrolumab in Systemic Lupus Erythematosus With Severe Hematological Manifestations: A Spanish Multicenter Study.
    J Rheumatol. 2025 Oct 1:jrheum.2025-0658. doi: 10.3899/jrheum.2025-0658.
    PubMed    
    
    
    
47. RUBINSTEIN TB, Touma Z, Blanco I, Knight AM, et al
    Improving Mental Health Care for People With Systemic Lupus Erythematosus: Time to Take Action.
    J Rheumatol. 2025 Oct 1:jrheum.2025-0922. doi: 10.3899/jrheum.2025-0922.
    PubMed    
    
    
    September 2025
48. SINGH JA, Beasley M
    Patient Resilience is associated with Better Patient-Reported Physical and Mental/Emotional Quality of Life in Systemic Lupus Erythematosus.
    J Rheumatol. 2025 Sep 15:jrheum.2025-0396. doi: 10.3899/jrheum.2025-0396.
    PubMed     Abstract available
    
    
    
49. YAU E, Chim T, Lim M, Inman RD, et al
    Anti-Integrin alphavbeta6 Autoantibodies as a Biomarker for Ulcerative Colitis in Patients With Axial Spondyloarthritis.
    J Rheumatol. 2025 Sep 15:jrheum.2024-1296. doi: 10.3899/jrheum.2024-1296.
    PubMed     Abstract available
    
    
    
50. YE C, Nikolic RPA, Choi M, Fifi-Mah AV, et al
    Canadian Rheumatology Association/Canadian Research Group of Rheumatology in Immuno-Oncology Living Guidelines for Baseline Immunosuppression in Individuals With Preexisting Rheumatic Diseases Initiating Immune Checkpoint Inhibitors. Part 2: Preexisti
    J Rheumatol. 2025 Sep 15:jrheum.2025-0482. doi: 10.3899/jrheum.2025-0482.
    PubMed     Abstract available
    
    
    
51. CONSOLARO A, Ruperto N, Lovell DJ, Synoverska O, et al
    Clinically Inactive Disease and Remission in Patients With Juvenile Idiopathic Arthritis Receiving Tofacitinib: Post Hoc Analysis of a Phase III Trial.
    J Rheumatol. 2025;52:919-926.
    PubMed     Abstract available
    
    
    
52. JUNEK ML, Chanchlani R, Rodriguez AR, Khalidi N, et al
    Assessment of giant cell arteritis-associated visual outcomes at a tertiary hospital in Ontario, Canada.
    J Rheumatol. 2025 Sep 1:jrheum.2025-0459. doi: 10.3899/jrheum.2025-0459.
    PubMed     Abstract available
    
    
    
53. ZAFFINO I, Boulard L, Law J, Danguecan A, et al
    Individual and Socio-ecological Resilience in Childhood-Onset Systemic Lupus Erythematosus: Associations with Patient Characteristics and Psychosocial Patient-Reported Outcomes.
    J Rheumatol. 2025 Sep 1:jrheum.2025-0375. doi: 10.3899/jrheum.2025-0375.
    PubMed     Abstract available
    
    
    
54. LIN CH, Lin YP
    Classic Magnetic Resonance Imaging Features Unmask Progressive Multifocal Leukoencephalopathy in Rituximab-Treated Neuropsychiatric Systemic Lupus Erythematosus.
    J Rheumatol. 2025 Sep 1:jrheum.2025-0410. doi: 10.3899/jrheum.2025-0410.
    PubMed    
    
    
    
55. HORN KW, Breneman A, Djavid AR, Boneparth AD, et al
    A Rare and Severe Cutaneous Presentation of Systemic Lupus Erythematosus.
    J Rheumatol. 2025 Sep 1:jrheum.2025-0367. doi: 10.3899/jrheum.2025-0367.
    PubMed    
    
    
    August 2025
56. PEDERSEN MJ, Host C, Hansen SN, Klotsche J, et al
    School Absence Among Children With Juvenile Idiopathic Arthritis: A National Matched Comparison Study.
    J Rheumatol. 2025;52:801-809.
    PubMed     Abstract available
    
    
    
57. ZIEMBA YC, Elkin EP, Kazemian E, Wilson BM, et al
    COVID-19 vaccine booster uptake and effectiveness among persons with systemic autoimmune and rheumatic diseases.
    J Rheumatol. 2025 Aug 1:jrheum.2025-0535. doi: 10.3899/jrheum.2025-0535.
    PubMed     Abstract available
    
    
    July 2025
58. EL TAL T, Steiman A, Knight A, Hiraki LT, et al
    A Pediatric-Adult Provider Dyad Care Model Improves Transition From Pediatric to Adult Healthcare For Youth with Childhood-onset Systemic Lupus Erythematosus.
    J Rheumatol. 2025 Jul 25:jrheum.2025-0046. doi: 10.3899/jrheum.2025-0046.
    PubMed     Abstract available
    
    
    
59. BRUNI C, Elhai M, Distler O
    Personalizing Management of Systemic Sclerosis-Associated Interstitial Lung Disease: Are Autoantibodies the Key for Risk Stratification?
    J Rheumatol. 2025 Jul 15:jrheum.2025-0692. doi: 10.3899/jrheum.2025-0692.
    PubMed    
    
    
    
60. PATEL H, DeMasters D, Tofferi J
    Antinuclear Antibody Multiplex Utilization Across a Large Federal Hospital System: An Investigation of Ordering Practices and Rheumatologic Outcomes.
    J Rheumatol. 2025;52:721-727.
    PubMed     Abstract available
    
    
    
61. KHAROUF F, Mehta P, Alhadri A, Li Q, et al
    Comparative Analysis of Damage Accrual in Lupus Nephritis Stratified by Biological Sex.
    J Rheumatol. 2025 Jul 1:jrheum.2025-0302. doi: 10.3899/jrheum.2025-0302.
    PubMed     Abstract available
    
    
    
62. KHAROUF F, Mehta P, Li Q, Gladman DD, et al
    Comparison of Lupus Nephritis Onset Before and After Age 50: Impact on Presentation and Outcomes in an Inception Cohort.
    J Rheumatol. 2025 Jul 1:jrheum.2024-1278. doi: 10.3899/jrheum.2024-1278.
    PubMed     Abstract available
    
    
    
63. TEAW S, Shojaee A, Carnaru M, Hinchcliff M, et al
    The Risk and Time Course for Autoimmune Rheumatic Disease Development in Patients With Raynaud Phenomenon.
    J Rheumatol. 2025 Jul 1:jrheum.2024-0954. doi: 10.3899/jrheum.2024-0954.
    PubMed    
    
    
    
64. COHEN-HAGAI K, Saban M, Benchetrit S, Bar-Ziv D, et al
    Prevalence, Risk Factors, and Outcomes of Chronic Kidney Disease in Systemic Lupus Erythematosus Patients with and without Lupus Nephritis.
    J Rheumatol. 2025 Jul 1:jrheum.2024-1087. doi: 10.3899/jrheum.2024-1087.
    PubMed     Abstract available
    
    
    
65. JUNEK ML, Okaj I, Patel S, Hu A, et al
    Multivariable models to predict a diagnosis of Giant Cell Arteritis: systematic review and meta-analysis.
    J Rheumatol. 2025 Jul 1:jrheum.2022-1204. doi: 10.3899/jrheum.2022-1204.
    PubMed     Abstract available
    
    
    
66. SMITH JD, Pan B, Keeling S
    Identifying the State of Mental Health Care in Canadian Adults with Systemic Lupus Erythematosus.
    J Rheumatol. 2025 Jul 1:jrheum.2025-0089. doi: 10.3899/jrheum.2025-0089.
    PubMed     Abstract available
    
    
    May 2025
67. GUNGORER V, Celik IK, Artac H, Celikel Acar B, et al
    OTULIN-Related Autoinflammatory Syndrome With a Novel Mutation Treated With Tumor Necrosis Factor Inhibitor Therapy: A Rare Case Report.
    J Rheumatol. 2025 May 15:jrheum.2024-1141. doi: 10.3899/jrheum.2024-1141.
    PubMed    
    
    
    
68. PIRES DA ROSA G, Granja BV, Azevedo F, Magina S, et al
    Pyoderma Gangrenosum-Associated Autoinflammatory Syndrome With Skin Abscesses: Successful Treatment With Anti-Interleukin 1 Therapy.
    J Rheumatol. 2025 May 15:jrheum.2025-0036. doi: 10.3899/jrheum.2025-0036.
    PubMed    
    
    
    
69. RODRIGUEZ-REYNA TS
    The Nuances of Shared Autoimmunity and the Singularity of Mixed Connective Tissue Disease.
    J Rheumatol. 2025 May 15:jrheum.2025-0463. doi: 10.3899/jrheum.2025-0463.
    PubMed    
    
    
    
70. JIANG Z, Barra L
    Does Prior Authorization for Tocilizumab Lead to Unacceptable Treatment Delays in Giant Cell Arteritis?
    J Rheumatol. 2025 May 15:jrheum.2025-0423. doi: 10.3899/jrheum.2025-0423.
    PubMed    
    
    
    
71. PLANTINGA LC, Roberts ET, Hoge C, Pearce BD, et al
    Indicators of Functional Disability by Receipt of Disability Benefits Among Individuals With Systemic Lupus Erythematosus.
    J Rheumatol. 2025;52:479-488.
    PubMed     Abstract available
    
    
    
72. PATTERSON SL, Ruvalcaba D, Issa A, Rai K, et al
    Experiences with Complementary and Integrative Health Among People with Rheumatoid Arthritis and Systemic Lupus Erythematosus: A Qualitative Study.
    J Rheumatol. 2025 May 1:jrheum.2024-1218. doi: 10.3899/jrheum.2024-1218.
    PubMed     Abstract available
    
    
    
73. KIM H
    Interferon Response Gene Score in Juvenile Dermatomyositis.
    J Rheumatol. 2025 May 1:jrheum.2025-0395. doi: 10.3899/jrheum.2025-0395.
    PubMed    
    
    
    March 2025
74. FETERMAN JIMENEZ D, Thomason JL, Liew JW, Ferguson S, et al
    Delays in Tocilizumab Therapy for Patients With Giant Cell Arteritis in the United States.
    J Rheumatol. 2025 Mar 15:jrheum.2024-0988. doi: 10.3899/jrheum.2024-0988.
    PubMed     Abstract available
    
    
    
75. ICHIKAWA T, Kishida D, Shimojima Y, Yajima N, et al
    Trust in Health Information Sources Among Patients with Systemic Lupus Erythematosus in the Social Networking Era: The TRUMP(2)-SLE Study.
    J Rheumatol. 2025 Mar 15:jrheum.2024-1088. doi: 10.3899/jrheum.2024-1088.
    PubMed     Abstract available
    
    
    
76. MACMAHON J, Massumi M, Duong TT, Garrett RH, et al
    Interferon Response Gene Score in Juvenile Dermatomyositis Correlates Strongly with Disease Activity.
    J Rheumatol. 2025 Mar 15:jrheum.2024-0806. doi: 10.3899/jrheum.2024-0806.
    PubMed     Abstract available
    
    
    
77. GENER KR, Simakova E, Handal M
    Concurrent IgG4-Related Disease and Giant Cell Arteritis: A Rare Case Study.
    J Rheumatol. 2025 Mar 1:jrheum.2024-0861. doi: 10.3899/jrheum.2024-0861.
    PubMed    
    
    
    
78. AGUILA T, Madan R, Palmer MB, Derk CT, et al
    Zebra Bodies in Kidney Biopsy: Drug-Induced Phospholipidosis in a Patient With Systemic Lupus Erythematosus.
    J Rheumatol. 2025 Mar 1:jrheum.2024-1312. doi: 10.3899/jrheum.2024-1312.
    PubMed    
    
    
    February 2025
79. HIGHLAND KB, Chakravarty R, Georgi S, Han M, et al
    Patient Perspectives and Clinical Insights Into the Diagnostic Journey From Connective Tissue Disease to Pulmonary Arterial Hypertension.
    J Rheumatol. 2025 Feb 20:jrheum.2024-0613. doi: 10.3899/jrheum.2024-0613.
    PubMed    
    
    
    
80. AFLAKI M, Bargman JM
    Urine Protein Tests in Systematic Lupus Erythematosus: What Do They Mean?
    J Rheumatol. 2025 Feb 15:jrheum.2024-0910. doi: 10.3899/jrheum.2024-0910.
    PubMed     Abstract available
    
    
    
81. STOUSTRUP P, Kellenberger CJ, Host C, Kuseler A, et al
    Effects of Biologics on Temporomandibular Joint Inflammation in Juvenile Idiopathic Arthritis.
    J Rheumatol. 2025;52:173-180.
    PubMed     Abstract available
    
    
    
82. MUMTAZ S, Koster MJ, Warrington KJ
    Novel Photon-Counting Computed Tomography for the Evaluation of Large-Vessel Giant Cell Arteritis.
    J Rheumatol. 2025 Feb 1:jrheum.2024-1156. doi: 10.3899/jrheum.2024-1156.
    PubMed    
    
    
    
83. NISHAT F, Golding M, Merrill K, Protudjer JLP, et al
    Lived Education Experience of Young Adults with Childhood- and Adult-onset Systemic Lupus Erythematosus: A Multi-Centre Canadian Qualitative Study.
    J Rheumatol. 2025 Feb 1:jrheum.2024-0695. doi: 10.3899/jrheum.2024-0695.
    PubMed     Abstract available
    
    
    
84. ABEL G, Ansari MQ, Snyder MR, Tebo AE, et al
    Historical Perspective on Antinuclear Antibody Testing.
    J Rheumatol. 2025 Feb 1:jrheum.2023-1121. doi: 10.3899/jrheum.2023-1121.
    PubMed     Abstract available
    
    
    December 2024
85. GONZALEZ-GAY MA, Castaneda S, Ferraz-Amaro I
    Managing Giant Cell Arteritis With Tocilizumab: Relapses and Adverse Events.
    J Rheumatol. 2024 Dec 15:jrheum.2024-1204. doi: 10.3899/jrheum.2024-1204.
    PubMed    
    
    
    
86. HASLAK F, Kilic H, Sahin S, Hotaman B, et al
    Children With Type I Interferonopathy: Commonalities and Diversities in a Large Patient Cohort.
    J Rheumatol. 2024;51:1208-1217.
    PubMed     Abstract available
    
    
    
87. MAILLE M, Tounkara BS, Vagner D, Bagny K, et al
    Epidemiology of isolated Cutaneous Lupus Erythematosus in the multiethnic population of Reunion Island (France): a retrospective multicentric study.
    J Rheumatol. 2024 Dec 1:jrheum.2024-0661. doi: 10.3899/jrheum.2024-0661.
    PubMed     Abstract available
    
    
    November 2024
88. NAGASE FN, Fukui S, Takizawa N, Yamaguchi T, et al
    Tocilizumab for Giant Cell Arteritis: Clinical Outcomes Following Relapses and Tocilizumab Discontinuation Due to Adverse Events.
    J Rheumatol. 2024 Nov 15:jrheum.2024-0612. doi: 10.3899/jrheum.2024-0612.
    PubMed     Abstract available
    
    
    
89. PARIMI VP, Ravindran V
    Cardiovascular Health and Adverse Pregnancy Outcomes in Autoimmune Rheumatic Diseases.
    J Rheumatol. 2024 Nov 15:jrheum.2024-0828. doi: 10.3899/jrheum.2024-0828.
    PubMed    
    
    
    
90. RANDELL RL, Reeve BB, Weitzman ER, von Scheven E, et al
    Pain Interference in Juvenile Idiopathic Arthritis.
    J Rheumatol. 2024;51:1119-1124.
    PubMed     Abstract available
    
    
    
91. IMAI Y, Ota Y, Matsumoto K, Akiyama M, et al
    Performance of the 2022 ACR/EULAR Classification Criteria in Comparison With the European Medicines Agency Algorithm in Antineutrophil Cytoplasmic Antibody-Associated Vasculitis.
    J Rheumatol. 2024;51:1102-1110.
    PubMed     Abstract available
    
    
    
92. BRUNNER HI, Pacheco-Tena C, Louw I, Vega-Cornejo G, et al
    Intravenous Golimumab in Children With Polyarticular-Course Juvenile Idiopathic Arthritis: Long-Term Extension of an Open-Label Phase III Study.
    J Rheumatol. 2024;51:1125-1134.
    PubMed     Abstract available
    
    
    
93. LIEBER SB, Young SR, Shea Y, Gottesman SP, et al
    The Lived Experiences of Older Adults with Systemic Lupus Erythematosus: Patient Perspectives.
    J Rheumatol. 2024 Nov 1:jrheum.2024-0478. doi: 10.3899/jrheum.2024-0478.
    PubMed     Abstract available
    
    
    
94. ARDALAN K, Rider LG
    Ringing in the Patient Voice: Measuring Patients' Lived Experience of Dermatomyositis Symptoms.
    J Rheumatol. 2024 Nov 1:jrheum.2024-0951. doi: 10.3899/jrheum.2024-0951.
    PubMed     Abstract available
    
    
    
95. JIANG Y, Duarte-Garcia A, Putman M, Gazeley D, et al
    Incidence of Pneumocystis jirovecii Pneumonia and Prophylaxis-Associated Adverse Events Among Patients with Systemic Lupus Erythematosus.
    J Rheumatol. 2024 Nov 1:jrheum.2023-1038. doi: 10.3899/jrheum.2023-1038.
    PubMed     Abstract available
    
    
    October 2024
96. LIU X, Zhang J, Xu H, Kuang W, et al
    Epidemiological characteristics of patients with juvenile dermatomyositis in China: a multicenter study.
    J Rheumatol. 2024 Oct 15:jrheum.2024-0003. doi: 10.3899/jrheum.2024-0003.
    PubMed     Abstract available
    
    
    
97. ZAREK J, Lee J, Harakati D, Spitzer K, et al
    Vitamin K Antagonists for Pregnant Women With Antiphospholipid Antibodies: A Scoping Review.
    J Rheumatol. 2024;51:964-972.
    PubMed     Abstract available
    
    
    
98. OCAMPO-TORRES MC, Hernandez-Molina G, Criales-Vera S, Sanchez-Guerrero J, et al
    Coronary Artery Calcification Progression in Patients With Systemic Lupus Erythematosus.
    J Rheumatol. 2024;51:991-996.
    PubMed     Abstract available
    
    
    
99. NIETO RE, Alarcon GS, Arnaud L, Pons-Estel GJ, et al
    Finding the Role of Anifrolumab in the New Paradigm of Systemic Lupus Erythematosus Treatment.
    J Rheumatol. 2024 Oct 1:jrheum.2024-0900. doi: 10.3899/jrheum.2024-0900.
    PubMed     Abstract available
    
    
    September 2024
100. VYZHGA Y, Doria AS, Feldman BM, Tse SM, et al
     Mining for Gems: Early Detection of Calcinosis in Juvenile Dermatomyositis Using Low-Dose Computed Tomography.
     J Rheumatol. 2024 Sep 15:jrheum.2024-0594. doi: 10.3899/jrheum.2024-0594.
     PubMed     Abstract available
     
     
     
101. KUWANA M, Wakasugi N, Hashida T, Uno S, et al
     Update on Tacrolimus in Patients With Interstitial Pneumonia Associated With Polymyositis or Dermatomyositis: 3-Year Postmarketing Surveillance Follow-Up in Japan.
     J Rheumatol. 2024 Sep 15:jrheum.2024-0379. doi: 10.3899/jrheum.2024-0379.
     PubMed     Abstract available
     
     
     
102. AN J, Marwaha A, Laxer RM
     Autoinflammatory Diseases: A Review.
     J Rheumatol. 2024;51:848-861.
     PubMed     Abstract available
     
     
     August 2024
103. AIRES BP, Wobma H, Samad A, Chandler MT, et al
     Severe Features of Systemic Juvenile Idiopathic Arthritis in Patients With Congenital Heart Disease.
     J Rheumatol. 2024;51:811-817.
     PubMed     Abstract available
     
     
     
104. KARABUKAYEVA A, Hearld LR, Choi S, Singh JA, et al
     Patient Perspectives on a Decision Aid for Systemic Lupus Erythematosus: Insights and Future Considerations.
     J Rheumatol. 2024;51:798-803.
     PubMed     Abstract available
     
     
     
105. PEDERSEN MJ, Host C, Hansen SN, Klotsche J, et al
     School Well-Being and Academic Performance of Children With Juvenile Idiopathic Arthritis: A National Register-Based Study.
     J Rheumatol. 2024;51:804-810.
     PubMed     Abstract available
     
     
     
106. GOLDER V, Kandane-Rathnayake R, Louthrenoo W, Chen YH, et al
     Comparison of Attainment and Protective Effects of Lupus Low Disease Activity State in Patients With Newly Diagnosed Versus Established Systemic Lupus Erythematosus.
     J Rheumatol. 2024;51:790-797.
     PubMed     Abstract available
     
     
     
107. OKITA Y, Okamoto M, Fujimoto J, Kumanogoh A, et al
     Pneumocephalus and Cerebral Abscess in Granulomatosis With Polyangiitis.
     J Rheumatol. 2024;51:832.
     PubMed    
     
     
     
108. YAMADA H, Sugiyama T, Ito Y, Toriihara A, et al
     Detection of Pancreatitis and Protein-Losing Gastroenteropathy Associated With Systemic Lupus Erythematosus by Protein Leakage Scintigraphy.
     J Rheumatol. 2024 Aug 1:jrheum.2024-0468. doi: 10.3899/jrheum.2024-0468.
     PubMed     Abstract available
     
     
     
109. CHRISTOPHER-STINE L, Ciesluk A, Chinoy H, Goyal NA, et al
     The Dermatomyositis Disease Symptom Questionnaire (DM-DSQ): A Measure to Assess the Patient Experience of Dermatomyositis Symptoms.
     J Rheumatol. 2024 Aug 1:jrheum.2023-1137. doi: 10.3899/jrheum.2023-1137.
     PubMed     Abstract available
     
     
     
110. GARG S, Plantinga LC
     A Bitter Pill to Swallow: The Challenge of Medication Nonadherence in Systemic Lupus Erythematosus.
     J Rheumatol. 2024 Aug 1:jrheum.2024-0654. doi: 10.3899/jrheum.2024-0654.
     PubMed     Abstract available
     
     
     July 2024
111. BOWDISH DME, Chandran V, Hitchon CA, Kaplan GG, et al
     When Should I Get My Next COVID-19 Vaccine? Data From the Surveillance of Responses to COVID-19 Vaccines in Systemic Immune-Mediated Inflammatory Diseases (SUCCEED) Study.
     J Rheumatol. 2024;51:721-727.
     PubMed     Abstract available
     
     
     
112. BAGGETT KH, Brandon TG, Xiao R, Weiss PF, et al
     Association of Infant Breastfeeding and Juvenile Spondyloarthritis: A Case-Control Study.
     J Rheumatol. 2024;51:708-714.
     PubMed     Abstract available
     
     
     
113. TANI C, Cardelli C, Zen M, Moroni L, et al
     Anifrolumab In Refractory Systemic Lupus Erythematosus: A Real-Life, Multicenter Study.
     J Rheumatol. 2024 Jul 1:jrheum.2024-0053. doi: 10.3899/jrheum.2024-0053.
     PubMed     Abstract available
     
     
     
114. TELES MS, Brundage J, Chiang TP, Alejo JL, et al
     Prevalence and Risk Factors of Post-Acute Sequela of COVID-19 in Adults with Systemic Autoimmune Rheumatic Diseases.
     J Rheumatol. 2024 Jul 1:jrheum.2023-1212. doi: 10.3899/jrheum.2023-1212.
     PubMed     Abstract available
     
     
     June 2024
115. UGARTE-GIL MF, Alarcon GS
     Low Disease Activity Early in the Course of Systemic Lupus Erythematosus.
     J Rheumatol. 2024 Jun 15:jrheum.2024-0502. doi: 10.3899/jrheum.2024-0502.
     PubMed     Abstract available
     
     
     
116. DHITAL R, Baer RJ, Bandoli G, Chambers C, et al
     Cardiovascular Events During Pregnancy: Implications for Adverse Pregnancy Outcomes in Individuals With Autoimmune and Rheumatic Diseases.
     J Rheumatol. 2024 Jun 15:jrheum.2024-0306. doi: 10.3899/jrheum.2024-0306.
     PubMed     Abstract available
     
     
     
117. KOBAYASHI H, Yoshida Y, Kida T, Yajima N, et al
     Seasonal Effects on Relapse of Antineutrophil Cytoplasmic Antibody-Associated Vasculitis: A Retrospective Multicenter Cohort Study in Japan (J-CANVAS).
     J Rheumatol. 2024;51:646-648.
     PubMed    
     
     
     
118. KWOK TSH, Zhou AL, Nguyen EL, Kwan A, et al
     Preliminary Development of a Novel Tool to Document Vessel Wall Involvement in Patients With Large-Vessel Vasculitis.
     J Rheumatol. 2024;51:637-639.
     PubMed    
     
     
     
119. MISZTAL MC, Gold N, Cao J, Diaz T, et al
     Genetics of Neonatal Lupus Erythematosus Risk and Specific Manifestations.
     J Rheumatol. 2024 Jun 1:jrheum.2023-1036. doi: 10.3899/jrheum.2023-1036.
     PubMed     Abstract available
     
     
     
120. SUN K, Molokwu NJ, Hanlen-Rosado E, Corneli AL, et al
     Implementation of a clinician-led medication adherence intervention among patients with systemic lupus erythematosus.
     J Rheumatol. 2024 Jun 1:jrheum.2024-0071. doi: 10.3899/jrheum.2024-0071.
     PubMed     Abstract available
     
     
     May 2024
121. KANIECKI T, Moyers B, Lubinus M, Hu YP, et al
     Patient Perspectives of the Manifestations and Treatment of Anti-MDA5 Antibody-Positive Dermatomyositis: An Observational Survey.
     J Rheumatol. 2024 May 15:jrheum.2024-0108. doi: 10.3899/jrheum.2024-0108.
     PubMed     Abstract available
     
     
     
122. AKPOIGBE O, Anim-Koranteng C, Tasmin R, Sammut A, et al
     A Rare Case of Anti-Mi-2 Antibody-Positive Dermatomyositis Associated With Gastrointestinal Stromal Tumor.
     J Rheumatol. 2024 May 15:jrheum.2024-0114. doi: 10.3899/jrheum.2024-0114.
     PubMed     Abstract available
     
     
     
123. AVASARALA J, Das S, Keshavamurthy S
     Point-of-Care Ultrasound With Artificial Intelligence-Driven Diagnostics in Giant Cell Arteritis: Blindness Prevention on a Global Scale.
     J Rheumatol. 2024 May 15:jrheum.2024-0217. doi: 10.3899/jrheum.2024-0217.
     PubMed     Abstract available
     
     
     
124. BRIDGES JM, Li J, Mannion ML, Clowse MEB, et al
     Contraception Care Patterns for Adult Females With Juvenile Idiopathic Arthritis on Teratogens in the Rheumatology Informatics System for Effectiveness (RISE) Registry.
     J Rheumatol. 2024;51:542-545.
     PubMed    
     
     
     April 2024
125. SEMALULU T, Berard R, Beattie K, Basodan D, et al
     Clinical Characteristics of Adolescents With Juvenile Idiopathic Arthritis Transitioning to Adult Rheumatology Care in Canada: Results From the CAPRI Registry.
     J Rheumatol. 2024;51:403-407.
     PubMed     Abstract available
     
     
     
126. OWN M, Bloostein A, Spiera R, Berman JR, et al
     Systemic Sclerosis in Individuals With Exposure to World Trade Center Ground Zero Rescue and Recovery Efforts: A Case Series.
     J Rheumatol. 2024;51:390-395.
     PubMed     Abstract available
     
     
     
127. CONTRERAS MARTIN GN
     Lupus Nephritis Treatment Strategies.
     J Rheumatol. 2024 Apr 1:jrheum.2024-0172. doi: 10.3899/jrheum.2024-0172.
     PubMed     Abstract available
     
     
     
128. JUNEK M, Barra L, Kopp A, Felfeli T, et al
     Phase Specific Health Care Costs Associated with Giant Cell Arteritis in Ontario, Canada.
     J Rheumatol. 2024 Apr 1:jrheum.2023-1245. doi: 10.3899/jrheum.2023-1245.
     PubMed     Abstract available
     
     
     
129. ROBERTS JE, Faino A, Bryan MA, Cogen JD, et al
     Hospitalization and Mortality due to Infection among United States Children and Adolescents with Systemic Lupus Erythematosus.
     J Rheumatol. 2024 Apr 1:jrheum.2023-1219. doi: 10.3899/jrheum.2023-1219.
     PubMed     Abstract available
     
     
     March 2024
130. YAMAMOTO H, Taniguchi Y
     Cranial Giant Cell Arteritis and Subdural Hematoma.
     J Rheumatol. 2024 Mar 15:jrheum.2024-0008. doi: 10.3899/jrheum.2024-0008.
     PubMed     Abstract available
     
     
     
131. YENNEMADI AS, Jordan N, Diong S, Keane J, et al
     The Link Between Dysregulated Immunometabolism and Vascular Damage: Implications for the Development of Atherosclerosis in Systemic Lupus Erythematosus and Other Rheumatic Diseases.
     J Rheumatol. 2024;51:234-241.
     PubMed     Abstract available
     
     
     
132. FALASINNU T, Nguyen T, Jiang TE, Tamang S, et al
     The Problem of Pain in Rheumatology: Variations in Case Definitions Derived From Chronic Pain Phenotyping Algorithms Using Electronic Health Records.
     J Rheumatol. 2024;51:297-304.
     PubMed     Abstract available
     
     
     
133. YASUDA N, Yamane T
     Leg Gangrene in Granulomatosis With Polyangiitis.
     J Rheumatol. 2024;51:316-317.
     PubMed    
     
     
     
134. PATEL NJ, Wang X, Lin M, Kowalski EN, et al
     Factors Associated with an Electronic Health Record-Based Definition of Post-Acute Sequelae of COVID-19 in Patients with Systemic Autoimmune Rheumatic Disease.
     J Rheumatol. 2024 Mar 1:jrheum.2023-1092. doi: 10.3899/jrheum.2023-1092.
     PubMed     Abstract available
     
     
     
135. DAWOUD SA, Ahmad NU, Shriver EM, Chung SM, et al
     Orbital and Optic Nerve Sheath Involvement and Pupil-Involving Cranial Nerve 3 Palsy in Giant Cell Arteritis.
     J Rheumatol. 2024 Mar 1:jrheum.2023-1195. doi: 10.3899/jrheum.2023-1195.
     PubMed     Abstract available
     
     
     
136. MORAND EF, Jones SA
     Flare in Systemic Lupus Erythematosus: Lost in Translation?
     J Rheumatol. 2024 Mar 1:jrheum.2024-0122. doi: 10.3899/jrheum.2024-0122.
     PubMed     Abstract available
     
     
     February 2024
137. TAKEUCHI T, Wakasugi N, Hashida T, Uno S, et al
     Long-term safety and effectiveness of tacrolimus in patients with lupus nephritis in Japan: 10-year analysis of the real-world TRUST study.
     J Rheumatol. 2024 Feb 15:jrheum.2023-0210. doi: 10.3899/jrheum.2023-0210.
     PubMed     Abstract available
     
     
     
138. WALSH M, Strouse J, Bettendorf B
     Paget Disease as a Rare Mimicker of Giant Cell Arteritis.
     J Rheumatol. 2024 Feb 15:jrheum.2023-1160. doi: 10.3899/jrheum.2023-1160.
     PubMed     Abstract available
     
     
     
139. SAGY I, Schwarzfuchs O, Zeller L, Ling E, et al
     Short- and Long-Term Mortality of Hospitalized Patients with Autoimmune Rheumatic Diseases and Serious Infections: A National Cohort Study.
     J Rheumatol. 2024 Feb 1:jrheum.2023-1063. doi: 10.3899/jrheum.2023-1063.
     PubMed     Abstract available
     
     
     
140. ALPERS CE
     Antiphospholipid Antibodies (aPL) and Thrombotic Microangiopathy for the Diagnosis of aPL Nephropathy: You Can't Have One Without the Other.
     J Rheumatol. 2024;51:109-111.
     PubMed    
     
     
     
141. PEDERSEN MJ, Host C, Hansen SN, Deleuran BW, et al
     Psychiatric Morbidity Is Common Among Children With Juvenile Idiopathic Arthritis: A National Matched Cohort Study.
     J Rheumatol. 2024;51:181-188.
     PubMed     Abstract available
     
     
     December 2023
142. ROGERS JL, Clowse MEB, McKenna K, Starling S, et al
     Patient and physician perspectives of systemic lupus erythematosus flare: A qualitative study.
     J Rheumatol. 2023 Dec 15:jrheum.2023-0721. doi: 10.3899/jrheum.2023-0721.
     PubMed     Abstract available
     
     
     
143. SKYDEL JJ, Ramachandran R, Suttiratana S, Ross JS, et al
     Geographic and Demographic Representation in Industry-Sponsored, US-Based Clinical Trials of Systemic Lupus Erythematosus Therapies.
     J Rheumatol. 2023 Dec 15:jrheum.2023-0920. doi: 10.3899/jrheum.2023-0920.
     PubMed     Abstract available
     
     
     November 2023
144. TOUMA Z, Parodis I, Strand V
     More Evidence on the Validity of the Measurement Properties of PROMIS Computerized Adaptive Tests in Systemic Lupus Erythematosus.
     J Rheumatol. 2023 Nov 15:jrheum.2023-0947. doi: 10.3899/jrheum.2023-0947.
     PubMed     Abstract available
     
     
     
145. RUBENSTEIN E, Maldini C, Vaglio A, Bello F, et al
     Cluster Analysis to Explore Clinical Subphenotypes of Eosinophilic Granulomatosis With Polyangiitis.
     J Rheumatol. 2023;50:1446-1453.
     PubMed     Abstract available
     
     
     
146. ROZENBLYUM EV, Chan MO, Gakhal NK
     Chew on This: The Afterbite of Temporomandibular Joint Involvement in Adults With Juvenile Idiopathic Arthritis.
     J Rheumatol. 2023;50:1364-1366.
     PubMed    
     
     
     
147. RUPERTO N, Lovell DJ, Berman A, Anton J, et al
     Abatacept as Monotherapy and in Combination With Methotrexate in Patients With Juvenile Idiopathic Arthritis: Analysis of 2 Phase III Trials.
     J Rheumatol. 2023;50:1471-1480.
     PubMed     Abstract available
     
     
     
148. DE SONNAVILLE WFC, Speksnijder CM, Zuithoff NPA, Heijstek MW, et al
     Clinically Established Temporomandibular Involvement in Adults With Juvenile Idiopathic Arthritis.
     J Rheumatol. 2023;50:1462-1470.
     PubMed     Abstract available
     
     
     
149. OGURO N, Yajima N, Ishikawa Y, Sakurai N, et al
     Impact of Attending Rheumatologist's Big Five Personality Traits on Systemic Lupus Erythematosus Patients' Trust: The TRUMP2-SLE Project.
     J Rheumatol. 2023 Nov 1:jrheum.2023-0603. doi: 10.3899/jrheum.2023-0603.
     PubMed     Abstract available
     
     
     October 2023
150. SUN YS, Huang DF, Chen WS, Liao HT, et al
     Risk factor and incidence of serious infections in systemic lupus erythematosus patients undergoing rituximab therapy.
     J Rheumatol. 2023 Oct 15:jrheum.2023-0623. doi: 10.3899/jrheum.2023-0623.
     PubMed     Abstract available
     
     
     
151. PARREAU S, Dumonteil S, Gondran G, Bezanahary H, et al
     Frequency and Significance of Hepatic Involvement in New-Onset Giant Cell Arteritis: A Study of 514 Patients.
     J Rheumatol. 2023 Oct 15:jrheum.2023-0358. doi: 10.3899/jrheum.2023-0358.
     PubMed     Abstract available
     
     
     
152. KAWANO Y, Wang X, Patel NJ, Qian G, et al
     Breakthrough COVID-19 after tixagevimab/cilgavimab among patients with systemic autoimmune rheumatic diseases.
     J Rheumatol. 2023 Oct 15:jrheum.2023-0742. doi: 10.3899/jrheum.2023-0742.
     PubMed     Abstract available
     
     
     
153. NIETO-GONZALEZ JC, Garulo DC, Boteanu A, Trives-Folguera L, et al
     What to Expect When Systemic Treatment in Juvenile Idiopathic Arthritis Is Withdrawn?
     J Rheumatol. 2023;50:1326-1332.
     PubMed     Abstract available
     
     
     
154. AGUIRRE A, DeQuattro K, Shiboski S, Katz P, et al
     Medication Cost Concerns and Disparities in Patient-Reported Outcomes Among a Multiethnic Cohort of Patients With Systemic Lupus Erythematosus.
     J Rheumatol. 2023;50:1302-1309.
     PubMed     Abstract available
     
     
     
155. LIU S, Han L, Li M, Tian X, et al
     Sex Differences in Clinical Manifestations of Hospitalized Patients With Eosinophilic Granulomatosis With Polyangiitis: A Retrospective Cohort Study.
     J Rheumatol. 2023;50:1318-1325.
     PubMed     Abstract available
     
     
     
156. QUINTANA R, Ramirez-Flores MF, Fuentes-Silva Y, Pelaez-Ballestas I, et al
     Diagnostic Delay in Autoimmune Rheumatic Diseases: A Global Health Problem.
     J Rheumatol. 2023 Oct 1:jrheum.2023-0847. doi: 10.3899/jrheum.2023-0847.
     PubMed     Abstract available
     
     
     September 2023
157. PESKIN M, Mostowy M, Velez J, Perron M, et al
     Clinical improvement in early onset interstitial lung disease using rituximab in children with anti-MDA5 positive juvenile dermatomyositis.
     J Rheumatol. 2023 Sep 15:jrheum.2023-0544. doi: 10.3899/jrheum.2023-0544.
     PubMed     Abstract available
     
     
     
158. SASAI T, Nakashima R, Tsuji H, Nakajima T, et al
     Long term prognosis of anti-melanoma differentiation-associated gene 5-positive dermatomyositis with interstitial lung disease.
     J Rheumatol. 2023 Sep 15:jrheum.2023-0371. doi: 10.3899/jrheum.2023-0371.
     PubMed     Abstract available
     
     
     
159. YOSHIDA Y, Nakamoto N, Oka N, Kidoguchi G, et al
     Seasonal Influence on Development of Antineutrophil Cytoplasmic Antibody-Associated Vasculitis: A Retrospective Cohort Study Conducted at Multiple Institutions in Japan (J-CANVAS).
     J Rheumatol. 2023;50:1152-1158.
     PubMed     Abstract available
     
     
     
160. WEISS PF, Brandon TG, Lambert RG, Biko DM, et al
     Consensus-Driven Definition for Unequivocal Sacroiliitis on Radiographs in Juvenile Spondyloarthritis.
     J Rheumatol. 2023;50:1173-1177.
     PubMed     Abstract available
     
     
     
161. MOISEEV S, Bulanov N, Crnogorac M, Direskeneli H, et al
     Traditional and Disease-Specific Risk Factors for Cardiovascular Events in Antineutrophil Cytoplasmic Antibody-Associated Vasculitis: A Multinational Retrospective Study.
     J Rheumatol. 2023;50:1145-1151.
     PubMed     Abstract available
     
     
     
162. FERUCCI ED
     Improving Outcomes in Systemic Lupus Erythematosus: The Importance of Access to Medications.
     J Rheumatol. 2023 Sep 1:jrheum.2023-0772. doi: 10.3899/jrheum.2023-0772.
     PubMed     Abstract available
     
     

Thank you for your interest in scientific medicine.

AMEDEO Autoimmune Disorders is free of charge. Privacy / Datenschutzerklärung | Imprint / Impressum